June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Evaluation of topical corneal therapeutic tissue cross-linking (TXL) using sodium hydroxymethylglycinate (SMG) by intravital confocal microscopy in rabbits
Author Affiliations & Notes
  • Mariya Zyablitskaya
    Columbia University, New York, New York, United States
  • Anna Takaoka
    Columbia University, New York, New York, United States
  • Alexandra H. Scanameo
    Columbia University, New York, New York, United States
  • Daeryl E. Amponin
    Columbia University, New York, New York, United States
  • Leejee H Suh
    Columbia University, New York, New York, United States
  • Stephen Trokel
    Columbia University, New York, New York, United States
  • Takayuki Nagasaki
    Columbia University, New York, New York, United States
  • David C Paik
    Columbia University, New York, New York, United States
  • Footnotes
    Commercial Relationships   Mariya Zyablitskaya, None; Anna Takaoka, None; Alexandra Scanameo , None; Daeryl Amponin , None; Leejee Suh, None; Stephen Trokel, None; Takayuki Nagasaki, None; David Paik, None
  • Footnotes
    Support  NCRR UL1RR024156, NEI P30 EY019007, NEI R01EY020495
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 4344. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Mariya Zyablitskaya, Anna Takaoka, Alexandra H. Scanameo, Daeryl E. Amponin, Leejee H Suh, Stephen Trokel, Takayuki Nagasaki, David C Paik; Evaluation of topical corneal therapeutic tissue cross-linking (TXL) using sodium hydroxymethylglycinate (SMG) by intravital confocal microscopy in rabbits. Invest. Ophthalmol. Vis. Sci. 2017;58(8):4344.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The success of riboflavin photochemical (CXL) corneal stabilization in keratoconus has proven that in vivo tissue cross-linking can be used as an effective therapy. Several drawbacks remain, however, and include the need for epithelial debridement and the use of ultraviolet-A irradiation. The current study was undertaken to evaluate the safe use of a candidate topical therapeutic tissue cross-linking (TXL) agent that is in current commercial use as a cosmetic preservative

Methods : Therapeutic tissue cross-linking using a 0.5-3% (40-250mM) solutions of sodium hydroxymethylglycinate (SMG) was carried out on Dutch-belted rabbits (n=10) using 3 different methods, a corneal reservoir (CR), viscous eyedrop (VE), and drug-soaked hydrogel contact lens (CL). The longest treatment was carried out on a weekly basis (7 times over 7 weeks) using 250mM solutions applied for 5 minutes via CR. The effects were followed in real time using intravital confocal microscopy (HRT3-RCM)

Results : The parameters for non-toxic cross-linking treatments were defined for CR, VE, and CL (250mM X 5 minutes for CR, 40mM twice daily for VE, and 40mM soaked etafilcon A (58% water content) CL applied for 15 minutes]. Confocal microscopy identified 3 major patterns of keratocyte change, particularly prominent during prolonged treatment via CR (7 treatments over 7 weeks). Anterior stromal keratocyte death occurred within the first few days of the initial treatment, mid stromal keratocyte activation (spindle-like) occurred from weeks 1-3, and anterior stromal keratocyte activation (syncytial-like) occurred beginning at week 3. Corneal thickness, endothelial cell density, and epithelial defect changes were not significantly affected by any method of application

Conclusions : Topical application of a 3% SMG solution (for 5 minutes) via a corneal reservoir method appears to be safe to the rabbit cornea and induces a wound healing response in the corneal stroma. Similar changes by confocal microscopy have been reported for CXL albeit at later time points. In addition, three different methods for safe topical application of SMG TXL solution are possible and include a CR, VE, and CL. These methods holds promise for clinical use since neither epithelial debridement nor UVA irradiation are necessary

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

 

HRT-RCM images for 2 corneal depths - control and treated eye over 2,5 months period

HRT-RCM images for 2 corneal depths - control and treated eye over 2,5 months period

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×